QUAKER HOUGHTON ANNOUNCES THIRD QUARTER 2026 RESULTS

QUAKER CHEMICAL CORP (KWR) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 NEWS Contact: John Dalhoff Director, Investor Relations investor@quakerhoughton.com T. 1.610.684.7822 For Release: Immediate QUAKER HOUGHTON ANNOUNCES THIRD QUARTER 2026 RESULTS • Q3’26 net sales of $544.5 million, an increase of 10% Y/Y • Q3’26 net income of $30.0 m

Event · Earnings
Also in this documentBuyback · $3.3M

Facts are quoted from the filing text and checked against it.

Original reporting
Published Oct 29, 2026, 8:34 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 29, 2026, 8:35 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$KWR
Bullish
high confidence
Mentioned
$KWR
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$KWRBullishMed
01

Why it matters

The earnings beat may trigger short‑term buying pressure, but investors should watch for seasonal slowdown and raw‑material cost trends.

02

Market read

The earnings release provides fresh quantitative data that can move KWR's stock and offers insight into industrial chemicals demand.

03

What to watch

Sequential decline expected due to seasonal demand could temper the rally.

Relevance 7/10Novelty 7/10Timing: immediate release after market close
AlphAI · Earnings readKWR · Q3 2026 · ended September 30, 2026

QUAKER HOUGHTON ANNOUNCES THIRD QUARTER 2026 RESULTS

✓Solid quarter

Net sales increased 10% year-over-year, non-GAAP earnings per diluted share increased 15% year-over-year, and adjusted EBITDA increased 8%, supported by new business wins across all segments. GAAP net income and diluted EPS declined modestly, while margins faced higher input costs and SG&A expenses and operating cash flow declined for the nine-month period.

Revenue
$545M
10% y/y · approximately 2% q/q
Americas
$254M
14 % y/y
Gross margin · non-GAAP
35.5 %
EPS · non-GAAP
$2.39
15% y/y

Key metrics

shortened, hover for the filing’s print
MetricValueq/qy/y
Q3 2026 net salesGAAP$544.5Mapproximately 2%10%
Nine months ended September 30, 2026 net salesGAAP$1.56B––
Q3 2026 gross profitGAAP$193.5M––
Nine months ended September 30, 2026 gross profitGAAP$559.5M––
Q3 2026 non-GAAP gross profitnon-GAAP$193.5M––
Q3 2026 non-GAAP gross marginnon-GAAP35.5 %––
Nine months ended September 30, 2026 non-GAAP gross marginnon-GAAP35.9 %––
Q3 2026 selling, general and administrative expensesGAAP$136.4M––
Nine months ended September 30, 2026 selling, general and administrative expensesGAAP$412.7M––
Q3 2026 operating incomeGAAP$48.85M––
Nine months ended September 30, 2026 operating incomeGAAP$123.0M––
Q3 2026 non-GAAP operating incomenon-GAAP$63.13M––
Q3 2026 non-GAAP operating marginnon-GAAP11.6 %––
Nine months ended September 30, 2026 non-GAAP operating incomenon-GAAP$163.8M––
Nine months ended September 30, 2026 non-GAAP operating marginnon-GAAP10.5 %––
Q3 2026 net income attributable to Quaker Chemical CorporationGAAP$29.98M––
Nine months ended September 30, 2026 net income attributable to Quaker Chemical CorporationGAAP$76.48M––
Q3 2026 diluted earnings per share attributable to Quaker Chemical Corporation common shareholdersGAAP$1.73––
Nine months ended September 30, 2026 diluted earnings per share attributable to Quaker Chemical Corporation common shareholdersGAAP$4.40––
Q3 2026 non-GAAP net incomenon-GAAP$41.41M––
Nine months ended September 30, 2026 non-GAAP net incomenon-GAAP$107.7M––
Q3 2026 non-GAAP earnings per diluted sharenon-GAAP$2.39–15%
Nine months ended September 30, 2026 non-GAAP earnings per diluted sharenon-GAAP$6.20––
Q3 2026 adjusted EBITDAnon-GAAP$89.78M–approximately 8%
Q3 2026 adjusted EBITDA marginnon-GAAP16.5 %––
Nine months ended September 30, 2026 adjusted EBITDAnon-GAAP$247.5M––
Nine months ended September 30, 2026 adjusted EBITDA marginnon-GAAP15.9 %––
Nine months ended September 30, 2026 net cash provided by operating activitiesGAAP$47.58M––

Segments

SegmentRevenueq/qy/y
AmericasAn increase in sales volumes and an increase in selling price and product mix.$254.0M–14 %
EMEAAn increase in selling price and product mix, partially offset by a decrease in sales volumes resulting from the reversal of pre-buy activity in the second quarter, and an unfavorable impact of foreign currency translation.$152.5M–6 %
Asia/PacificAn increase in sales volumes, an increase in selling price and product mix, and a favorable impact of foreign currency translation.$138.1M–9 %

Amounts quoted below without a unit are in thousands, as in the filing’s tables. Per-share figures are as printed.

Fourth quarter of 2026 outlook

  • NoteFourth quarter revenue and adjusted EBITDA will improve year-over-year but decline sequentially from the third quarter’s record level in line with normal seasonal demand patterns from the holiday season in North America and EMEA.
  • NoteActivity in Asia is expected to remain soft in the fourth quarter.
  • NoteGlobal raw material costs will remain elevated through the end of the year.

Capital returns

  • In the third quarter of 2026, the Company repurchased 21,781 shares for $3.3 million.
  • Shares purchased under share repurchase programs were $27,480 for the nine months ended September 30, 2026, compared to $36,496 for the nine months ended September 30, 2025.
  • Dividends paid were $26,368 for the nine months ended September 30, 2026, compared to $25,583 for the nine months ended September 30, 2025.

What drove it

  • Consolidated sales volumes increased 3% year-over-year, primarily driven by new business wins across all segments.
  • Selling price and product mix increased 7%, reflecting pricing actions to offset higher raw material costs, changes in product and service mix, and the impact of index-based customer contracts.
  • Underlying end market activity in the third quarter of 2026 was flat to slightly lower than prior year levels.
  • Adjusted EBITDA growth was primarily driven by higher net sales, partially offset by higher input costs and SG&A expenses.
  • Americas segment operating earnings increased due to higher net sales, partially offset by lower segment operating margins and higher SG&A.
  • EMEA segment operating earnings increased due to higher net sales and improved segment operating margins.

Concerns

  • Q3 2026 GAAP net income attributable to Quaker Chemical Corporation was $29,977, compared to $30,469 in the prior-year quarter.
  • Q3 2026 non-GAAP gross margin was 35.5 %, compared to 36.8 % in the prior-year quarter.
  • Q3 2026 non-GAAP operating margin was 11.6 %, compared to 11.7 % in the prior-year quarter.
  • Q3 2026 adjusted EBITDA margin was 16.5 %, compared to 16.8 % in the prior-year quarter.
  • Asia/Pacific segment operating earnings decreased compared to the prior-year quarter, primarily due to lower segment operating margins.
  • EMEA sales volumes declined 2 % year-over-year, following reversal of pre-buy activity in the second quarter.
  • Net cash provided by operating activities was $47,582 for the nine months ended September 30, 2026, compared to $89,909 for the same period in 2025, primarily reflecting higher net cash outflows from working capital.
  • The Company expects Asia activity to remain soft and global raw material costs to remain elevated through the end of the year.

What to watch

  • Whether new business wins continue to support sales-volume growth across all segments.
  • Fourth-quarter seasonal demand effects in North America and EMEA, where revenue and adjusted EBITDA are expected to decline sequentially.
  • Industrial demand in China and expected soft Asia activity in the fourth quarter.
  • Raw material costs and the effectiveness of pricing actions and index-based customer contracts in offsetting input cost inflation.
  • Working-capital cash outflows, including accounts receivable and inventory balances.

Balance sheet and cash flow

  • Cash and cash equivalents were $167,006 as of September 30, 2026, compared to $179,829 as of December 31, 2025.
  • Total gross debt was $894.6 million as of September 30, 2026.
  • Net debt was approximately $727.6 million as of September 30, 2026.
  • Net debt divided by trailing twelve months adjusted EBITDA was approximately 2.3x.
  • Trailing twelve months adjusted EBITDA for the twelve-month period ended September 30, 2026 was $319.3 million.
  • Accounts receivable, net were $487,955 as of September 30, 2026, compared to $417,157 as of December 31, 2025.
  • Inventories were $319,612 as of September 30, 2026, compared to $265,776 as of December 31, 2025.
  • Investments in property, plant and equipment were $(32,466) for the nine months ended September 30, 2026, compared to $(33,630) for the nine months ended September 30, 2025.
  • Net cash used in investing activities was $(28,716) for the nine months ended September 30, 2026, compared to $(193,019) for the nine months ended September 30, 2025.
  • Net cash used in financing activities was $(30,759) for the nine months ended September 30, 2026, compared to $79,268 for the nine months ended September 30, 2025.

Analysis

Quaker Houghton reported Q3 2026 net sales of $544,548, up 10% from $493,842 in the prior-year quarter. The increase reflected a 3% increase in sales volumes and a 7% improvement in selling price and product mix. Management attributed volume growth to new business wins across all segments, while pricing and mix reflected actions to offset higher raw material costs, product and service mix changes, and index-based customer contracts. Consolidated net sales also increased approximately 2% compared to the second quarter of 2026.

All three segments grew revenue year-over-year. Americas net sales were $254,030 and increased 14 %, supported by 6 % volume growth and 8 % selling price and product mix. EMEA net sales were $152,466 and increased 6 %, as 10 % selling price and product mix more than offset a 2 % volume decline and a 2 % foreign-currency headwind. Asia/Pacific net sales were $138,052 and increased 9 %, supported by 5 % volume growth, 3 % selling price and product mix, and a 1 % favorable currency impact. Underlying end-market activity was flat to slightly lower than prior-year levels, making new business wins the key source of volume growth.

Profitability improved in dollar terms but showed pressure in reported non-GAAP margins. GAAP operating income rose to $48,853 from $46,641, and adjusted EBITDA increased to $89,781 from $82,851. Non-GAAP net income increased to $41,411 from $36,270, while non-GAAP diluted EPS rose to $2.39 from $2.08. However, Q3 non-GAAP gross margin was 35.5 % versus 36.8 %, non-GAAP operating margin was 11.6 % versus 11.7 %, and adjusted EBITDA margin was 16.5 % versus 16.8 %. Management identified higher input costs and SG&A expenses as partial offsets to the higher sales base. GAAP net income attributable to Quaker Chemical Corporation was $29,977, compared with $30,469, and diluted GAAP EPS was $1.73 compared with $1.75.

Cash conversion weakened over the nine-month period. Net cash provided by operating activities was $47,582, compared with $89,909 in the prior-year period, with the decline primarily reflecting higher working-capital outflows. Accounts receivable, net were $487,955 and inventories were $319,612 as of September 30, 2026, compared with $417,157 and $265,776, respectively, at December 31, 2025. The Company reported total gross debt of $894.6 million, cash and cash equivalents of $167.0 million, net debt of approximately $727.6 million, and net debt divided by trailing twelve months adjusted EBITDA of approximately 2.3x. It repurchased 21,781 shares for $3.3 million during the quarter.

For the fourth quarter, management expects revenue and adjusted EBITDA to improve year-over-year but decline sequentially from the third-quarter record level because of normal holiday-season demand patterns in North America and EMEA. Management also expects soft activity in Asia, elevated global raw material costs through year-end, and industrial-demand pressure in China due to geopolitical and economic uncertainty. The central issues for the next period are whether price and mix can continue to offset input inflation, whether new business wins can sustain volume growth against soft end markets, and whether working-capital outflows moderate.

Management, verbatim

Net sales increased 10% compared with the prior year, driven by new business wins across all segments, leading to a fifth consecutive quarter of year-over-year profitability improvement. Our results were led by strong growth in the Americas and improved operating earnings in EMEA despite end markets that remain challenged amid the backdrop of ongoing conflict in the Middle East. Asia Pacific continued to generate volume growth even as market conditions softened in China throughout the quarter. I am proud of our team’s consistent execution and ability to convert above-market growth into higher earnings, leading to our second consecutive quarter of record adjusted EBITDA.

Joe Berquist, Chief Executive Officer and President

Looking ahead, we anticipate fourth quarter revenue and adjusted EBITDA will improve year-over-year but decline sequentially from the third quarter’s record level in line with normal seasonal demand patterns from the holiday season in North America and EMEA. Activity in Asia is expected to remain soft in the fourth quarter as geopolitical and economic uncertainty have tempered industrial demand in China, and we anticipate global raw material costs will remain elevated through the end of the year as the conflict in the Middle East continues. We remain focused on advancing our transformation initiatives and carrying our positive earnings momentum into 2027.

Joe Berquist, Chief Executive Officer and President

Not in the filing

stated, not guessed
  • Prior-quarter revenue amount
  • GAAP gross margin
  • GAAP operating margin
  • GAAP tax rate
  • Free cash flow
  • Quantitative fourth-quarter revenue guidance
  • Quantitative fourth-quarter adjusted EBITDA guidance
  • Dividend per share
  • Prior outlook for comparison

Written by an AI language model from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure is checked against the filing text, and a metric the filing does not print, or whose value, prior period and change do not add up, is dropped from the metrics. Guided figures in the outlook comparison come from the company’s previous release. The model can still misread a table, in the metrics or in the text, so check a number in the filing before you rely on it. Consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.

Background

Quaker Houghton (NYSE:KWR) released its Q3 2026 results via an SEC Form 8‑K, highlighting sales growth and margin improvement across all segments.

Company-level read

Ticker impact

$KWRBullishHigh confidence
Context

Q3 2026 earnings release showing 10% YoY sales growth and improved margins.

Expected impact

likely upward pressure as investors price in stronger top‑line growth and higher non‑GAAP earnings.

Evidence & confidence

The company reported higher sales, higher non‑GAAP net income and record adjusted EBITDA, which typically supports a price rally.

Market effects

Industrial chemicals sector may see modest upside as Quaker Houghton's growth signals demand resilience.

North America and EMEA markets could benefit from the upbeat outlook.

Limited to specialty chemicals niche; broader market impact minimal.

Counterpoint

Higher raw material costs could pressure margins in upcoming quarters, potentially limiting upside.

Key entities

  • Joe Berquist

    CEO who commented on the results and outlook.

Every KWR earnings report

This story covers one filing. The ticker page keeps them all: each quarter's reported metrics with year-over-year and sequential comparisons, segments, guidance, and how the numbers landed against the company's own prior outlook.

Related articles

$KWRMed

Quaker Houghton Q3 Earnings Call Highlights

Quaker Houghton (KWR) reported Q3 earnings, noting 4% growth in North American steel production and 9% Asia Pacific sales increase. Gross margin held at 35.5%, despite raw-material cost pressures. The company expects stable margins in Q4 but seasonal volume declines. Q3 operating cash flow was $14M, down from $51M YoY. KWR forecasts full-year adjusted EBITDA growth in the high-single-digit percentage range.

$KWRMedAI 8/10

Quaker Houghton (KWR) (Q3 2026) Earnings Call Highlights: Record EBITDA, 10% Sales Growth

Quaker Houghton (KWR) reported Q3 2026 with record EBITDA, 10% sales growth, and 35.5% gross margin, down 130 bps YoY due to raw material costs. Operating cash flow was $48M, below recent periods. The company expects Q4 raw material inflation and a seasonal volume decline, particularly in Asia Pacific. CEO Joseph Berquist discussed margin trajectory, pricing strategies, and regional outlooks, aiming for 36%-37% gross margins in 2027.

$KWRMedAI 8/10

QUAKER HOUGHTON ANNOUNCES THIRD QUARTER 2026 RESULTS

Quaker Houghton (NYSE: KWR) reported Q3 2026 net sales of $544.5M, up 10% Y/Y, with net income of $30.0M and EPS of $1.73. Non-GAAP net income was $41.4M, up 15% Y/Y. Sales volume increased 3% Y/Y due to new business wins. Adjusted EBITDA rose 8% Y/Y to $89.8M. The company expects Q4 revenue and EBITDA to improve Y/Y but decline sequentially due to seasonal demand and global economic uncertainties.